Abstract:Organophosphate esters (OPEs) can exhibit various toxicities including endocrine disruption activity. Unfortunately, the low-dose endocrine-disrupting effects mediated by estrogen receptors (ERs) are commonly underestimated for OPEs and their metabolites. Here, structure-oriented research was performed to investigate the estrogenic/antiestrogenic effect of 13 OPEs (including three metabolites) and the potential mechanism. All of the OPEs exerted antiestrogenic activities in both E-screen and MVLN assays. OPEs with bulky substituents, such as phenyl rings (triphenyl phosphate (TPP), tricresyl phosphate (TCP), diphenylphosphoryl chloride, and diphenylphosphite) or relatively long alkyl chains (dibutylbutylphosphonate (DBBP)), exerted relatively strong ER antagonism potency at micromolar concentrations. The established quantitative structure–activity relationship indicated that the antiestrogenic activities of the OPEs mainly depended on the volume, leading eigenvalue, and hydrophobicity of the molecule. Molecular docking revealed that the three OPEs with the bulkiest substituents on the phosphate ester group (TPP, TCP, and DBBP) have a similar interaction mode to the classical ER antagonist 4-hydroxytamoxifen. The correlation between the antiestrogenic activity and the corresponding ER binding affinity was statistically significant, strongly suggesting that the OPEs possess the classical antagonism mechanism of interfering with the positioning of helix 12 in the ER.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.est.0c04376?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.est.0c04376</a>.Docking scores, molecular parameters, and activity data of OPEs (Table S1); RNA isolation and reverse transcription polymerase chain reaction (RT-PCR) (Part 1); the process of QSAR development and the robustness of the QSAR model (Part 2); antiproliferation effect of each OPE in the E-screen assay under single exposure scenario (Figure S1); antiluciferase activities of OPEs after cotreatment with E2 in the MVLN assay (Figure S2); empirical distribution of R2* for the PEC50 model in the antiproliferation activity of OPEs (cotreatment with E2) in the E-screen assay (Figure S3); empirical distribution of R2* for the PEC50 model in the antiluciferase activity of OPEs (exposure alone) in the MVLN assay (Figure S4); empirical distribution of R2* for the PEC50 model in the antiluciferase activity of OPEs (cotreatment with E2) in the MVLN assay (Figure S5); and the binding modes of five OPE molecules in hERα-LBD (Figure S6) (<a class="ext-link" href="/doi/suppl/10.1021/acs.est.0c04376/suppl_file/es0c04376_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Determination of the Binding Affinities of OPEs to Integrin Αvβ3 and Elucidation of the Underlying Mechanisms Via a Competitive Binding Assay, Pharmacophore Modeling, Molecular Docking and QSAR Modeling.

Determination of the binding affinities of OPEs to integrin α v β 3 and elucidation of the underlying mechanisms via a competitive binding assay, pharmacophore modeling, molecular docking and QSAR modeling

Integration of Nontarget Screening and QSPR Models to Identify Novel Organophosphate Esters of High Priority in Aquatic Environment

Computational Evaluation of Interactions Between Organophosphate Esters and Nuclear Hormone Receptors.

A green approach coupled with molecular dynamics simulations and toxicity assays to infer the mode of action for organophosphate esters

Predicting the acute toxicity of organophosphate esters (OPEs) to aquatic organisms by modelling the structure-toxicity relationships using partial least square regression

Determination and Prediction of the Binding Interaction Between Organophosphate Flame Retardants and P53.

The Interaction Between Organic Phosphate Ester and P53: an Integrated Experimental and in Silico Approach.

Aggravating Pollution of Emerging Aryl Organophosphate Esters in Urban Estuarine Sediments of South China

Elucidating the Toxicity Mechanisms of Organophosphate Esters by Adverse Outcome Pathway Network.

The potential connections of adverse outcome pathways with the hazard identifications of typical organophosphate esters based on toxicity mechanisms

Structure-Oriented Research on the Antiestrogenic Effect of Organophosphate Esters and the Potential Mechanism

Spatial heterogeneity, sediment-water exchange, and diffusion mechanisms of organophosphate esters from river to coastal aquatic system in a typical economic circle of northern China

Influence of watershed characteristics and human activities on the occurrence of organophosphate esters related to dissolved organic matter in estuarine surface water

Analytical methods and pollution status of organophosphate flame retardants

Insights into organophosphate esters (OPEs) in aquatic ecosystems: Occurrence, environmental behavior, and ecological risk

Potential adverse outcome pathways with hazard identification of organophosphate esters

New Insights into the Visual Toxicity of Organophosphate Esters: An Integrated Quantitative Adverse Outcome Pathway and Cross-chemical Extrapolation

Unveiling the Occurrence and Potential Ecological Risks of Organophosphate Esters in Municipal Wastewater Treatment Plants Across China

Organophosphate Esters in Reservoir Water from a Metropolitan City in the Guangdong-Hong Kong-Macao Greater Bay Area, China, and Their Ecological Risk

Concentration Levels and Ecological Risk Assessment of Typical Organophosphate Esters in Representative Surface Waters of a Megacity